RLX Technology Reports 2022 Fiscal Year Financial Performance

Mar.10.2023
RLX Technology Reports 2022 Fiscal Year Financial Performance
RLX Technology released unaudited financial results showing a year-on-year decline in revenue and profit for 2022.

On March 10th, RLX Technology, also known as Yuè Kè, announced its unaudited financial results for the year ended December 31st, 2022, and its Q4 financial results on the NASDAQ website. The company's consolidated financial report showed that its net revenue for the full year of 2022 was RMB 5.33 billion, a 37.41% decrease compared to RMB 8.52 billion in 2021. Its net profit for 2022 was RMB 1.409 billion, compared to RMB 2.028 billion in 2021.


Financial summary for the fourth quarter of 2022.


The net revenue for the fiscal year 2022 was 340 million yuan (49.3 million USD), which is a decrease of 82.14% compared to the same period in 2021, where it was 1.9044 billion yuan. The gross profit margin for the year was 43.6%, compared to last year's 40.2%. The net loss under US GAAP was 225.1 million yuan (32.6 million USD), while last year's net profit under US GAAP was 494.4 million yuan. The non-US GAAP net income for the year was 249.7 million yuan (36.2 million USD), compared to last year's 536.5 million yuan. This is a summary of the financial results for the fiscal year 2022.


In the fiscal year of 2022, the net revenue for the company was 53.328 billion Yuan (7.732 billion USD), a decrease from the previous year's revenue of 85.210 billion Yuan. The gross profit margin for 2022 was 43.2%, slightly higher than the previous year's margin of 43.1%. Under the Generally Accepted Accounting Principles in the United States, the net revenue for 2022 was 14.087 billion Yuan (2.042 billion USD), down from the previous year's revenue of 20.281 billion Yuan. The non-US GAAP net revenue for 2022 was 15.749 billion Yuan (2.283 billion USD), a decrease from the previous year's revenue of 22.515 billion Yuan.


References:


RLX Technology has released its financial results for the fourth quarter and fiscal year 2022, which have not been audited.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Jinjia Shares Discloses 2025 Annual and Q1 2026 Results With Revenue Growth, Profit Pressure and Expanding New Tobacco Business
Jinjia Shares Discloses 2025 Annual and Q1 2026 Results With Revenue Growth, Profit Pressure and Expanding New Tobacco Business
Jinjia Shares’ 2025 annual report summary and first-quarter 2026 report show that the company recorded 2025 revenue of RMB 2.988 billion, up 4.57% year on year, while net profit attributable to shareholders turned to a loss of RMB 346 million. In the first quarter of 2026, revenue rose 58.13% year on year to RMB 1.005 billion, but attributable net profit fell 45.16% to RMB 36.5349 million. The company said both revenue and cost growth were related to the expansion of its new tobacco business.
Apr.28 by 2FIRSTS.ai
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai
Imperial Tobacco Canada Responds to Anti-Smoking Groups on Youth Vaping
Imperial Tobacco Canada Responds to Anti-Smoking Groups on Youth Vaping
Imperial Tobacco Canada responded to the April 17 press conference by anti-smoking groups by calling for a more focused, fact-based discussion on youth vaping that targets the illicit market. The company said youth should not be using nicotine products and that it supports strong measures to prevent youth access, but argued that the discussion failed to clearly distinguish between the regulated market and the illicit market that is driving youth access.
Apr.22 by 2FIRSTS.ai
Turkey’s New Tobacco Bill Draft Would Cover E-Cigarettes and Heated Tobacco Products
Turkey’s New Tobacco Bill Draft Would Cover E-Cigarettes and Heated Tobacco Products
A Turkey’s draft would impose major limits on the use of tobacco products in public buildings, educational and healthcare institutions, children’s areas, and outdoor events, while setting a 2040 target for a complete ban on the production, sale, and consumption of tobacco products. The draft also broadens the definition of tobacco products to include e-cigarettes, heated tobacco products, and all nicotine-containing systems.
Apr.13 by 2FIRSTS.ai
Indonesian drug agency chief proposes ban on e-cigarettes and e-liquid containing harmful substances
Indonesian drug agency chief proposes ban on e-cigarettes and e-liquid containing harmful substances
Indonesian drug agency chief proposes ban on e-cigarette and e-liquid in new draft law, citing dangerous substances found.
Apr.08 by 2FIRSTS.ai
Swedish Politicians Ask European Commission to Clarify Legality of France’s Nicotine Pouch Ban
Swedish Politicians Ask European Commission to Clarify Legality of France’s Nicotine Pouch Ban
France’s ban on oral nicotine pouches has triggered an immediate response in Sweden. Swedish Minister for Foreign Trade Benjamin Dousa said Sweden had mobilized strongly against the ban and argued that it constitutes a clear obstacle to the free movement of goods within the EU single market. Swedish officials say the measure affects a strategically important domestic industry and conflicts with Sweden’s harm-reduction approach to public health.
Apr.14 by 2FIRSTS.ai